Drug Profile
Fibroblast growth factor - ViaCell
Alternative Names: dFGF - ViaCell; Dimerised fibroblast growth factor - ViaCellLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Massachusetts Institute of Technology
- Developer ViaCell
- Class Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 09 Apr 2008 Discontinued - Preclinical for Stroke in USA (unspecified route)
- 08 Nov 2005 No development reported - Preclinical for Stroke in USA (unspecified route)
- 02 Sep 2002 Preclinical trials in Stroke in USA (unspecified route)